CN104359991B - 一种新的碱式依卡倍特铋有关物质的检测方法 - Google Patents
一种新的碱式依卡倍特铋有关物质的检测方法 Download PDFInfo
- Publication number
- CN104359991B CN104359991B CN201410668696.5A CN201410668696A CN104359991B CN 104359991 B CN104359991 B CN 104359991B CN 201410668696 A CN201410668696 A CN 201410668696A CN 104359991 B CN104359991 B CN 104359991B
- Authority
- CN
- China
- Prior art keywords
- ecabet
- bismuth
- solution
- alkali formula
- mobile phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- IWCWQNVIUXZOMJ-MISYRCLQSA-N ecabet Chemical compound OC(=O)[C@@](C)([C@@H]1CC2)CCC[C@]1(C)C1=C2C=C(C(C)C)C(S(O)(=O)=O)=C1 IWCWQNVIUXZOMJ-MISYRCLQSA-N 0.000 title claims abstract description 31
- 229950003246 ecabet Drugs 0.000 title claims abstract description 31
- 229910052797 bismuth Inorganic materials 0.000 title claims abstract description 28
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 title claims abstract description 28
- 239000003513 alkali Substances 0.000 title claims abstract description 26
- 239000000126 substance Substances 0.000 title claims abstract description 22
- 238000001514 detection method Methods 0.000 title description 8
- 238000000034 method Methods 0.000 claims abstract description 30
- 239000007788 liquid Substances 0.000 claims abstract description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims abstract description 9
- 230000014759 maintenance of location Effects 0.000 claims abstract description 9
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims abstract description 8
- 235000019796 monopotassium phosphate Nutrition 0.000 claims abstract description 8
- WSGYTJNNHPZFKR-UHFFFAOYSA-N 3-hydroxypropanenitrile Chemical compound OCCC#N WSGYTJNNHPZFKR-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000000945 filler Substances 0.000 claims abstract description 6
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 6
- 238000010828 elution Methods 0.000 claims abstract description 5
- 230000035945 sensitivity Effects 0.000 claims abstract description 5
- 230000001105 regulatory effect Effects 0.000 claims abstract description 3
- 238000012360 testing method Methods 0.000 claims description 38
- 239000000243 solution Substances 0.000 claims description 34
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 27
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 14
- 238000004811 liquid chromatography Methods 0.000 claims description 5
- 238000004090 dissolution Methods 0.000 claims description 3
- 238000012937 correction Methods 0.000 claims description 2
- 239000011259 mixed solution Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 239000012535 impurity Substances 0.000 description 28
- 239000012071 phase Substances 0.000 description 12
- 238000004128 high performance liquid chromatography Methods 0.000 description 10
- 238000000926 separation method Methods 0.000 description 10
- 230000015556 catabolic process Effects 0.000 description 7
- 238000006731 degradation reaction Methods 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000000047 product Substances 0.000 description 5
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000001590 oxidative effect Effects 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 241000590002 Helicobacter pylori Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- NAYRZLVSOLIQSH-UHFFFAOYSA-N acetonitrile;methanol;phosphoric acid Chemical compound OC.CC#N.OP(O)(O)=O NAYRZLVSOLIQSH-UHFFFAOYSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 230000009854 mucosal lesion Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- REFMEZARFCPESH-UHFFFAOYSA-M sodium;heptane-1-sulfonate Chemical compound [Na+].CCCCCCCS([O-])(=O)=O REFMEZARFCPESH-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
Landscapes
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410668696.5A CN104359991B (zh) | 2014-11-21 | 2014-11-21 | 一种新的碱式依卡倍特铋有关物质的检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410668696.5A CN104359991B (zh) | 2014-11-21 | 2014-11-21 | 一种新的碱式依卡倍特铋有关物质的检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104359991A CN104359991A (zh) | 2015-02-18 |
CN104359991B true CN104359991B (zh) | 2016-04-20 |
Family
ID=52527272
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410668696.5A Active CN104359991B (zh) | 2014-11-21 | 2014-11-21 | 一种新的碱式依卡倍特铋有关物质的检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104359991B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101590031A (zh) * | 2008-06-17 | 2009-12-02 | 浙江爱生药业有限公司 | 磺化去氢松香酸二钠、其组合物及其应用 |
CN103713064A (zh) * | 2014-01-07 | 2014-04-09 | 珠海亿邦制药股份有限公司 | 一种用高效液相色谱法测定碱式依卡倍特铋有关物质的方法 |
-
2014
- 2014-11-21 CN CN201410668696.5A patent/CN104359991B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101590031A (zh) * | 2008-06-17 | 2009-12-02 | 浙江爱生药业有限公司 | 磺化去氢松香酸二钠、其组合物及其应用 |
CN103713064A (zh) * | 2014-01-07 | 2014-04-09 | 珠海亿邦制药股份有限公司 | 一种用高效液相色谱法测定碱式依卡倍特铋有关物质的方法 |
Non-Patent Citations (4)
Title |
---|
Dan Zhang 等.Determination of ecabet in human plasma by high-performance liquid chromatography–tandem mass spectrometry.《Journal of Chromatography B》.2008,第863卷223-228. * |
刘广娟 等.HPLC测定依卡倍特钠颗粒有关物质及其含量.《中国现代应用医学》.2012,第29卷(第1期),70-72. * |
王晶 等.人尿中磺化脱氢松香酸和铋的测定及尿药排泄特征研究.《中国药学杂志》.2012,第47卷(第10期),825-829. * |
谢春.高效液相色谱法测定碱式依卡倍特铋干混悬剂中有机酸根的含量.《海峡药学》.2010,第22卷(第12期),86-87. * |
Also Published As
Publication number | Publication date |
---|---|
CN104359991A (zh) | 2015-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108982709A (zh) | 一种奥美拉唑干混悬剂中有关物质的检测方法 | |
CN107238672A (zh) | 一种异烟肼或其药物组合物中杂质的含量测定方法 | |
CN104914185A (zh) | 一种法匹拉韦中有关物质的hplc测定方法 | |
CN102375033B (zh) | 盐酸苯达莫司汀及其有关物质的高效液相色谱分析方法 | |
CN102213698B (zh) | 一种甘油磷酰胆碱注射液有关物质的检测方法 | |
CN105017243B (zh) | 一种头孢曲松钠光降解产物及其制备方法和分析检测方法 | |
CN102507825B (zh) | 一种防治骨质疏松中药护骨胶囊的有效成分的检测方法 | |
CN105301159A (zh) | 一种西罗莫司的高效液相色谱分析方法 | |
CN107703230A (zh) | 一种盐酸溴己新有关物质的高效液相色谱检测法 | |
CN105467021A (zh) | 一种hplc法分离测定帕立骨化醇原料药及制剂中有关物质的方法 | |
CN104359991B (zh) | 一种新的碱式依卡倍特铋有关物质的检测方法 | |
CN106706769B (zh) | 一种恩格列净及其光学异构体的分离测定方法 | |
Satheesh et al. | UPLC separation and quantification of related substances of varenicline tartrate tablet | |
CN107064377A (zh) | 一种检测复方维生素c和l‑左卡尼汀咀嚼片中左卡尼汀含量的方法 | |
CN104280473A (zh) | 一种利奈唑胺注射液中5-羟甲基糠醛的分析方法 | |
CN108398497B (zh) | 一种三(壬基酚)亚磷酸酯的高效液相色谱检测方法 | |
CN103134886A (zh) | 一种hplc法分析分离伊班膦酸钠及杂质的方法 | |
CN108169362B (zh) | 一种用液相色谱法分离卡马西平及有关物质的方法 | |
CN109580834A (zh) | 一种含胞磷胆碱钠的药物制剂中有关物质的检测方法 | |
CN103713064B (zh) | 一种用高效液相色谱法测定碱式依卡倍特铋有关物质的方法 | |
CN104965031B (zh) | 复方酮洛芬奥美拉唑缓释胶囊的含量测定方法 | |
CN111189937B (zh) | 阿司匹林原料药有关物质的液相检测分离方法 | |
CN102636582A (zh) | 测定三氮脒颗粒中三氮脒和安替比林含量的方法 | |
CN109030668B (zh) | 钆塞酸二钠中间体的高效液相分析方法 | |
CN108181419B (zh) | 一种萘二磺乙乳胆铵原料或其制剂有关物质的检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 519041 Guangdong province Zhuhai Sanzao Road No. 9 East Coast Co-patentee after: YIBANG GUOCHUANG INSTITUTE OF MATERIA MEDICA (BEIJING) Co.,Ltd. Patentee after: Zhuhai Yibang Pharmaceutical Co.,Ltd. Address before: 519041 Guangdong province Zhuhai Sanzao Road No. 9 East Coast Co-patentee before: YIBANG GUOCHUANG INSTITUTE OF MATERIA MEDICA (BEIJING) Co.,Ltd. Patentee before: ZHUHAI EBANG PHARMACEUTICAL Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 519041 Guangdong province Zhuhai Sanzao Road No. 9 East Coast Patentee after: Zhuhai Yibang Pharmaceutical Co.,Ltd. Patentee after: National Institute for drug research (Beijing) Co.,Ltd. Address before: 519041 Guangdong province Zhuhai Sanzao Road No. 9 East Coast Patentee before: Zhuhai Yibang Pharmaceutical Co.,Ltd. Patentee before: YIBANG GUOCHUANG INSTITUTE OF MATERIA MEDICA (BEIJING) Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Kong Xiaodie Inventor after: Wu Haoshan Inventor before: Zhang Zaifu Inventor before: Wu Haoshan Inventor before: Xu Xinwen |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210202 Address after: 102629 room 409-36, 4 / F, building 1, 38 Yongda Road, Daxing biomedical industrial base, Zhongguancun Science and Technology Park, Daxing District, Beijing (cluster registration) Patentee after: Beijing aoxinda Pharmaceutical Research Institute Co.,Ltd. Address before: 519041 No.9, East jinhaian Avenue, Sanzao, Jinwan District, Zhuhai City, Guangdong Province Patentee before: Zhuhai Yibang Pharmaceutical Co.,Ltd. Patentee before: National Institute for drug research (Beijing) Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 102629 3rd floor, building 16, courtyard 50, Huatuo Road, Daxing biomedical industrial base, Zhongguancun Science and Technology Park, Daxing District, Beijing Patentee after: AoXin sunshine (Beijing) Pharmaceutical Technology Co.,Ltd. Address before: 102629 room 409-36, 4 / F, building 1, 38 Yongda Road, Daxing biomedical industrial base, Zhongguancun Science and Technology Park, Daxing District, Beijing (cluster registration) Patentee before: Beijing aoxinda Pharmaceutical Research Institute Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 102629 3rd floor, building 16, courtyard 50, Huatuo Road, Daxing biomedical industrial base, Zhongguancun Science and Technology Park, Daxing District, Beijing Patentee after: Beijing Haiyi Pharmaceutical Co.,Ltd. Address before: 102629 3rd floor, building 16, courtyard 50, Huatuo Road, Daxing biomedical industrial base, Zhongguancun Science and Technology Park, Daxing District, Beijing Patentee before: AoXin sunshine (Beijing) Pharmaceutical Technology Co.,Ltd. |